Traffic pollution may worsen Alzheimer's disease in susceptible individuals.
Traffic-related air pollution exacerbates AD-relevant phenotypes in a genetically susceptible rat model via neuroinflammatory mechanism(s)
This study looks at how air pollution from traffic might impact the development and worsening of Alzheimer's disease in specially modified rats, helping us understand how breathing in these pollutants could affect brain health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11083673 on NIH RePORTER |
What this research studies
This research investigates how exposure to traffic-related air pollution (TRAP) affects the development and severity of Alzheimer's disease (AD) in a genetically modified rat model. The study uses a unique exposure model that mimics real-world pollution levels from a major freeway, allowing researchers to observe the effects of TRAP on neuroinflammation and neurodegeneration. By examining the relationship between lung inflammation and brain health, the research aims to identify specific components of vehicle emissions that contribute to AD-like symptoms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a genetic predisposition to Alzheimer's disease or those living in areas with high traffic pollution.
Not a fit: Patients without a genetic risk for Alzheimer's disease or those not exposed to significant traffic-related air pollution may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention strategies for Alzheimer's disease related to environmental factors.
How similar studies have performed: Previous studies have shown a correlation between air pollution and neurodegenerative diseases, but this specific approach using real-time TRAP exposure in a rat model is relatively novel.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Lein, Pamela J — University of California at Davis
- Study coordinator: Lein, Pamela J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.